[The future of ESWL].
With the introduction of the Dornier HM3 lithotripter, the successful history of extracorporeal shock wave lithotripsy (ESWL) for noninvasive treatment of urinary stones began about 25 years ago. The development of newer lithotripters has not been able to improve clinical efficacy because the shock wave parameters specifically responsible for stone disintegration or tissue trauma and pain induction have not yet been identified. Actual research in lithotripter technology deals with modification of the focal point. The evolution of endoscopic procedures, ureterorenoscopy, and percutaneous nephrolithotomy took longer but was more successful in terms of clinical efficacy. Nowadays, ESWL or an endoscopic procedure is offered as a reasonable option for most urinary stone cases. Therefore, economic aspects and the surgeon's expertise will become greater factors when a procedure is chosen. ESWL, with or without anaesthesia, will be an inherent part of future treatment modalities for urinary stones.
Köhrmann
K U
KU
Urologische Abteilung, Theresienkrankenhaus und St. Hedwig-Klinik GmbH, Bassermannstrasse 1, 68165, Mannheim, Deutschland. kai.uwe.koehrmann@theresienkrankenhaus.de
Neisius
D
D
Rassweiler
J
J
D003131:Combined Modality Therapy; D004867:Equipment Design; D005544:Forecasting; D006801:Humans; D007669:Kidney Calculi / Q000628:therapy*; D008096:Lithotripsy / Q000295:instrumentation / Q000639:trends*; D009403:Nephrostomy, Percutaneous / Q000639:trends; D016896:Treatment Outcome; D014514:Ureteral Calculi / Q000628:therapy*; D018666:Ureteroscopy / Q000639:trends